Channel 9 is proud to partner with St. Jude for their Dream Home Giveaway – another way St. Jude raises money to make sure ...

The following is a summary of “Natural Progression of Pineal Cysts in Relation to Headache: A Prospective Observational Study ...

Five-year-old Harry Salm was misdiagnosed with a common school bug just months before his parents received a devastating ...

Glioblastoma, one of the most aggressive and lethal brain cancers, has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. While the relationship between ...

Brain Surgeon: A Doctor’s Inspiring ... At Cedars-Sinai we have isolated stem cells in glioblastoma tumors. This discovery may have far-reaching implications.” In another aspect of this ...

A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

About Genenta Genenta (Nasdaq: GNTA) is a clinical stage immuno-oncology company developing a proprietary hematopoietic stem cells therapy for the treatment of a variety of solid tumor cancers.

By singling out a protein they say is involved in the growth of glioblastoma, scientists say they can create targeted ...

Glioblastoma (GBM), one of the most aggressive types of brain cancer, is one of the greatest challenges for medicine, both ...

Glioblastoma stem cells with fluorescent labeling for prion protein (red), CD44 protein (green), and cell nucleus (blue) ...